Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transfonning growth factor-β1

被引:68
作者
Gekker, Genya [1 ]
hu, Sxian Hu [1 ]
Sheng, Wen S. [1 ]
Rock, R. Bryan [1 ]
Lokensgard, James R. [1 ]
Peterson, Phillip K. [1 ]
机构
[1] Univ Minnesota, Sch Med, Dept Med, Ctr Infect Dis & Microbiol Translat Res, Minneapolis, MN 55455 USA
关键词
microglia; HIV-1; cocaine; sigma-1; receptor; transforming growth factor-beta 1;
D O I
10.1016/j.intimp.2005.12.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The neuropharmacological properties of cocaine are known to be associated with the activation of sigma-1 receptors. Cocaine also has been shown to alter both cytokine production and HIV-1 expression in mononuclear phagocytes, including microglial cells. This study tested the hypothesis that sigma-l receptors and transforming growth factor (TGF)-beta 1 are involved in cocaine-induced up-regulation of HIV-1 expression in microglial cell cultures. Treatment of microglial cells with cocaine resulted in a concentration-dependent increase in viral expression assessed by measurement of p24 antigen levels in culture supernatants. This cocaine-mediated stimulation of HIV-1 expression was blocked by treatment of microglia with inhibitors of sigma-l receptors (BD1047) and TGF-beta 1 (SB-431542 and anti-TGF-beta 1 antibodies). Microglia were also shown to constitutively express sigma-1 receptor mRNA. Thus, the results of this study support the notion that neuroimmunopharmacological properties of cocaine involve sigma-1 receptors and cytokines. (c) 2005 Published by Elsevier B.V.
引用
收藏
页码:1029 / 1033
页数:5
相关论文
共 16 条
[1]   The transforming growth factor-βs:: Structure, signaling, and roles in nervous system development and functions [J].
Böttner, M ;
Krieglstein, K ;
Unsicker, K .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (06) :2227-2240
[2]   Microbial infections, immunomodulation, and drugs of abuse [J].
Friedman, H ;
Newton, C ;
Klein, TW .
CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (02) :209-+
[3]   Cocaine modulates cytokine and enhances tumor growth through sigma receptors [J].
Gardner, B ;
Zhu, LX ;
Roth, MD ;
Tashkin, DP ;
Dubinett, SM ;
Sharma, S .
JOURNAL OF NEUROIMMUNOLOGY, 2004, 147 (1-2) :95-98
[4]   κ-opioid receptor ligands inhibit cocaine-induced HIV-1 expression in microglial cells [J].
Gekker, G ;
Hu, SX ;
Wentland, MP ;
Bidlack, JM ;
Lokensgard, JR ;
Peterson, PK .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (02) :600-606
[5]   SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7 [J].
Inman, GJ ;
Nicolás, FJ ;
Callahan, JF ;
Harling, JD ;
Gaster, LM ;
Reith, AD ;
Laping, NJ ;
Hill, CS .
MOLECULAR PHARMACOLOGY, 2002, 62 (01) :65-74
[6]  
LAZDINS JK, 1991, J IMMUNOL, V147, P1201
[7]   TGF-BETA AND HIV-INFECTION [J].
LOTZ, M ;
SETH, P .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 685 :501-511
[8]   Sigma1 (σ1) receptor antagonists represent a new strategy against cocaine addiction and toxicity [J].
Maurice, T ;
Martin-Fardon, W ;
Romieu, P ;
Matsumoto, RR .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2002, 26 (04) :499-527
[9]   Two novel σ receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity [J].
McCracken, KA ;
Bowen, WD ;
de Costa, BR ;
Matsumoto, RR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 370 (03) :225-232
[10]   Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients [J].
Nair, MPN ;
Chadha, KC ;
Hewitt, RG ;
Mahajan, S ;
Sweet, A ;
Schwartz, SA .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (01) :96-100